Report overview
Hematological disorders deal with blood related diseases and generally affect the quantity or functionality of the cells or proteins present in the blood.
This report contains market size and forecasts of Drugs and Diagnostics for Hematological Disorders in Global, including the following market information:
Global Drugs and Diagnostics for Hematological Disorders Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drugs and Diagnostics for Hematological Disorders market was valued at 97320 million in 2021 and is projected to reach US$ 128670 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Analyzers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drugs and Diagnostics for Hematological Disorders include Abbot, Pfizer, Amgen, Beckman Coulter, Mindray, Roche, Biorad, Eli Lilly and Sysmex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs and Diagnostics for Hematological Disorders companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs and Diagnostics for Hematological Disorders Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drugs and Diagnostics for Hematological Disorders Market Segment Percentages, by Type, 2021 (%)
Analyzers
Reagents
Global Drugs and Diagnostics for Hematological Disorders Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drugs and Diagnostics for Hematological Disorders Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Drugs and Diagnostics for Hematological Disorders Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drugs and Diagnostics for Hematological Disorders Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs and Diagnostics for Hematological Disorders revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drugs and Diagnostics for Hematological Disorders revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbot
Pfizer
Amgen
Beckman Coulter
Mindray
Roche
Biorad
Eli Lilly
Sysmex
Bristol-Myers
Siemens
Horbia
Nihon Kohden
